Skip to Main Content

Paper Details

Tumour immune rejection triggered by activation of α2-adrenergic receptors.
Nature
11
2023
2-AR, 2-adrenergic receptors, 2a-AR, Adra2a, CD4, CD4 T lymphocytes, CD8, CD8 T lymphocytes, ICB, T cells, T lymphocytes, Tumour, Tumours, cancer, host cells, human, human lymphocytes, human tumour xenografts, immunodeficient, macrophages, mice, multiple immunocompetent tumour, myeloid, myeloid suppressor cells, patients, tumour, tumour cells, tumours

Datasets

Release 1.2